2025 Advanced Heart Failure Symposium

Welcome Introduction and Keynote: Worsening Heart Failure - Stage C Transitioning to Stage D

Objectives

• 1. Define and elucidate the concept of worsening heart failure, emphasizing its clinical significance and impact on patient outcomes.
• 2. Discuss the clinical manifestations and symptoms associated with worsening heart failure, such as dyspnea, fatigue, fluid retention, and their implications for patient management.
• 3. Describe the management of worsening heart failure from managing diuretics, disease modifying quadruple medical therapy for HF with reduced ejection fraction and consideration for adding vericiguat.

Session 1: Diuretics and Cardiorenal Syndrome in HF Patients

Objectives

• 1. Discuss the evaluation of kidney function in patients with stage C and D heart failure
• 2. Describe the best practices for inpatient and outpatient diuretic strategies utilizing oral Intravenous and subcutaneous adminsitration techniques

Session 2: Hemodynamics & Ambulatory Monitors

Objectives

• 1. Understand the principles of ambulatory hemodynamic monitoring (AHM) and the clinical evidence for heart failure management.
• 2. Discuss how AHM can enhance patient management by detecting early signs of hemodynamic deterioration, such as right ventricular failure or worsening heart failure, in patients with LVADs.
• 3. Review the challenges and limitations of implementing AHM in clinical practice and patient management.

Session 3: Dilated Cardiomyopathy

Objectives

• 1. The participant will be able to state the criteria for which you would order genetic counseling/genetic testing
• 2. The participant will be able to name 2 of the most common genetic diseases that are associated with cardiomyopathy

Rethinking Hyperkalemia Management in Patients on RAASi Therapy Sponsored by AstraZeneca

Session 4: Strategies for Managing the Cardiogenic Shock Patient

Objectives

• 1. Recall 2 strategies used to identify and manage a patient with cardiogenic shock both in the community and in the hospital
• 2. Discuss the importance of multidisciplinary team-based approach for managing the cardiogenic shock patient, including practical approach to the nurses and advanced practice providers role in a cardiogenic shock team.

Session 5: Temporary Devices: What to Do Now, What to Do Next?

Objectives

• 1. Describe the types of temporary mechanical support devices, indications, and complications.
• 2. Using case presentations, patient hemodynamics and imaging, determine the next steps in caring for patients on temporary mechanical circulatory support.

Session 6: Practical Tools for Maintaining Patients on Temporary Mechanical Circulatory Support

Objectives

• 1. Review the physical examination, diagnostic imaging, hemodynamics and laboratory findings determine whether patient is adequately responding to current level of temporary mechanical circulatory support
• 2. Recall current clinical pathways outlining steps to escalate or de-escalate percutaneous mechanical circulatory support

Session 7: Top 10 Takeaways from the 2024 Guidelines for the Evaluation and Care of the Cardiac Transplant Candidate

Objectives

• 1. Recall the key contemporary takaways from most recent evidence supporting the evaluation and care of cardiac transplant recipients.

Session 8: The Forgotten Ventricle

Objectives

• 1. The participant will be able to state the difference between the way the left and right ventricle work.
• 2. The participant will be able to name 2 therapies that are named at supporting the right ventricle for the long term.

Session 9: The Perks of Durable Devices: Ensuring Success in Long-term Durable VAD

Objectives

• 1. The participant will be able to name and explain to their patients, at least 2 of the primary benefits that patients can experience when living with Mechanical Circulatory Support.
• 2. The participant will be able to list at least 2 of the non-medical complications that can occur in the life of the patient and their significant others, while living on durable mechanical circulatory support

Session 10: Advanced HF Listing Conference: Case Presentation and Expert Input

Objectives

• 1. The participants will be able to apply the most common risk factors discussed in the VAD patient lectures, to the patients being evaluated for VAD placement.
• 2. The participants will be able to apply the signs/symptoms of Advanced Heart Failure, to the candidates being discussed for Adv HF therapies during the case presentations, to determine timing for listing/VAD placement.

Session 11: Envisioning the Future: Innovations and Strategies to Improve Advanced Heart Failure Care

Objectives

• 1. Describe current innovations in the field of cardiac transplantation and mechanical circulatory support.